New eye drops aim to improve corneal transplant outcomes in fuchs dystrophy
Disease control
Recruiting now
This study tests an experimental eye drop called DT-168 in people with Fuchs endothelial corneal dystrophy who are already scheduled for a corneal transplant. The goal is to see if the drops are safe and affect disease-related markers. About 28 adults aged 30 and older with a spe…
Phase: PHASE2 • Sponsor: Design Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC